Introduction into the NHS of magnetic sphincter augmentation: an innovative surgical therapy for reflux - results and challenges.

2.50
Hdl Handle:
http://hdl.handle.net/11287/620615
Title:
Introduction into the NHS of magnetic sphincter augmentation: an innovative surgical therapy for reflux - results and challenges.
Authors:
Prakash, D; Campbell, B.; Wajed, Saj A.
Abstract:
Introduction Gastro-oesophageal reflux disease (GORD) is a common, chronic debilitating condition. Surgical management traditionally involves fundoplication. Magnetic sphincter augmentation (MSA) is a new definitive treatment. We describe our experience of introducing this innovative therapy into NHS practice and report the early clinical outcomes. Methods MSA was introduced into NHS practice following successful acceptance of a cost-effective business plan and close observation of National Institute for Health and Care Excellence (NICE) recommendations for new procedures, including a carefully planned prospective data collection over a two-year follow-up period. Results Forty-seven patients underwent MSA over the 40-month period. Reflux health-related quality of life (GERD-HRQL) was significantly improved after the procedure and maintained at one- and two-year (P < 0.0001) follow-up. Drug dependency went from 100% at baseline to 2.6% and 8.7% after one and two years. High levels of patient satisfaction were reported. There were no adverse events. Conclusions MSA is highly effective in the treatment of uncomplicated GORD, with durable results and an excellent safety profile. This laparoscopic, minimally invasive procedure provides a good alternative for patients where surgical anatomy is unaltered. Our experience demonstrates that innovative technology can be incorporated into NHS practice with an acceptable business plan and compliance with NICE recommendations.
Citation:
Introduction into the NHS of magnetic sphincter augmentation: an innovative surgical therapy for reflux - results and challenges. 2018 Apr;100(4):251-256 Ann R Coll Surg Engl
Publisher:
Royal College of Surgeons
Journal:
Annals of the Royal College of Surgeons of England
Issue Date:
24-Jan-2018
URI:
http://hdl.handle.net/11287/620615
DOI:
10.1308/rcsann.2017.0224
PubMed ID:
29364013
Additional Links:
http://publishing.rcseng.ac.uk/doi/abs/10.1308/rcsann.2017.0224?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
Type:
Journal Article
Language:
en
ISSN:
1478-7083
Appears in Collections:
Upper Gastro-Intestinal Surgery; 2018 RD&E publications

Full metadata record

DC FieldValue Language
dc.contributor.authorPrakash, Den
dc.contributor.authorCampbell, B.en
dc.contributor.authorWajed, Saj A.en
dc.date.accessioned2018-02-13T15:39:24Z-
dc.date.available2018-02-13T15:39:24Z-
dc.date.issued2018-01-24-
dc.identifier.citationIntroduction into the NHS of magnetic sphincter augmentation: an innovative surgical therapy for reflux - results and challenges. 2018 Apr;100(4):251-256 Ann R Coll Surg Englen
dc.identifier.issn1478-7083-
dc.identifier.pmid29364013-
dc.identifier.doi10.1308/rcsann.2017.0224-
dc.identifier.urihttp://hdl.handle.net/11287/620615-
dc.description.abstractIntroduction Gastro-oesophageal reflux disease (GORD) is a common, chronic debilitating condition. Surgical management traditionally involves fundoplication. Magnetic sphincter augmentation (MSA) is a new definitive treatment. We describe our experience of introducing this innovative therapy into NHS practice and report the early clinical outcomes. Methods MSA was introduced into NHS practice following successful acceptance of a cost-effective business plan and close observation of National Institute for Health and Care Excellence (NICE) recommendations for new procedures, including a carefully planned prospective data collection over a two-year follow-up period. Results Forty-seven patients underwent MSA over the 40-month period. Reflux health-related quality of life (GERD-HRQL) was significantly improved after the procedure and maintained at one- and two-year (P < 0.0001) follow-up. Drug dependency went from 100% at baseline to 2.6% and 8.7% after one and two years. High levels of patient satisfaction were reported. There were no adverse events. Conclusions MSA is highly effective in the treatment of uncomplicated GORD, with durable results and an excellent safety profile. This laparoscopic, minimally invasive procedure provides a good alternative for patients where surgical anatomy is unaltered. Our experience demonstrates that innovative technology can be incorporated into NHS practice with an acceptable business plan and compliance with NICE recommendations.en
dc.language.isoenen
dc.publisherRoyal College of Surgeonsen
dc.relation.urlhttp://publishing.rcseng.ac.uk/doi/abs/10.1308/rcsann.2017.0224?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmeden
dc.rightsArchived with thanks to Annals of the Royal College of Surgeons of Englanden
dc.subjectWessex Classification Subject Headings::Gastroenterologyen
dc.titleIntroduction into the NHS of magnetic sphincter augmentation: an innovative surgical therapy for reflux - results and challenges.en
dc.typeJournal Articleen
dc.identifier.journalAnnals of the Royal College of Surgeons of Englanden
dc.type.versionPublisheden

Related articles on PubMed

All Items in RD&E Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.